Dose Response and Efficacy of GW842166 in Pain
NCT00554762 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2015-02-16
Summary
The purpose of this study is to assess the dose response and efficacy of single and repeat doses of GW842166 in healthy volunteers using pharmacodynamic pain assessments.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
GW842166X
Administer
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2008-03-31
- Completion
- 2008-03-31
More Related Trials
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
NCT00964990 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
NCT00710554 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain
NCT01019824 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
NCT01200524 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Pain Associated With Fibromyalgia
NCT02146430 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers
NCT00832546 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Neuropathic Pain Patients With Peripheral Nerve Injury
NCT00969059 ·Status: COMPLETED ·Phase: PHASE2
-
The Significance of Peripheral Input
NCT04764045 ·Status: UNKNOWN ·Phase: NA
-
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
NCT06595004 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety
NCT02065349 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain
NCT02301169 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain
NCT00976534 ·Status: TERMINATED ·Phase: PHASE2
-
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).
NCT05620576 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00376454 ·Status: COMPLETED ·Phase: PHASE2
-
Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies
NCT02842554 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
NCT06715462 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Management of Neuropathic Pain With Ramelteon
NCT00753623 ·Status: TERMINATED ·Phase: NA
-
Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia
NCT00809679 ·Status: TERMINATED ·Phase: PHASE2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain
NCT01043263 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
NCT00245544 ·Status: TERMINATED ·Phase: PHASE2
-
ACD440 Gel in Peripheral Neuropathic Pain
NCT05416931 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04707157 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
NCT01056315 ·Status: TERMINATED ·Phase: PHASE2